G1 Therapeutics, Inc. Financial Ratios — GTHX Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-84.01	-78.39	-35.8	-37.33	-38.67	-61.47	-66.76	-31
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	- -	- -	- -	100	93.6	92.69	91.28
EBITDA Margin (%)	-2,946.74	- -	- -	- -	- -	-211.76	-451.1	-264.42	-47.28
Operating Margin (%)	-2,954.79	- -	- -	- -	- -	-213.04	-452.59	-265.45	-47.91
Incremental Operating Margin (%)	- -	2,867.24	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3,881.8	- -	- -	- -	- -	-216.06	-468.38	-284.32	-54.36
Profit Margin (%)	-3,881.8	- -	- -	- -	- -	-219.18	-471.32	-287.63	-58.13
Net Income to Common Margin (%)	-4,155.17	- -	- -	- -	- -	-219.18	-471.32	-287.63	-58.13
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	6.58	12.7	7.33	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	- -	- -	- -	- -	10	28	83	84	56
ST Debt	- -	- -	- -	- -	1	- -	1	1	- -
LT Debt	- -	- -	- -	- -	10	28	82	83	56
Total Debt/EBITDA	- -	- -	- -	- -	-0.08	-0.29	-0.58	-0.62	-1.43
Net Debt/EBITDA	1.49	1.56	1.71	4.14	2.09	1.95	1.03	0.13	-0.5
Total Debt/EBIT	- -	- -	- -	- -	-0.08	-0.29	-0.58	-0.62	-1.41
Net Debt/EBIT	1.49	1.56	1.7	4.14	2.09	1.94	1.02	0.13	-0.49
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-53.93	-30.42	-13	-3.89
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-53.93	-30.42	-13.05	-3.89
EBIT to Interest Expense	- -	- -	- -	- -	- -	-54.26	-30.52	-13.05	-3.94
Interest Expense	- -	- -	- -	- -	- -	2	5	10	10
Common Equity/Total Assets	-132.6	-134.79	-122.77	-57.75	-118.26	-190.81	-230.02	-389.44	-641.75
Long-Term Debt/Equity (%)	- -	- -	- -	- -	3.73	15.65	57.08	120.19	157.96
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-2.92	-6.8	-16.34	-12.75	-7.72
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	3.35	12.15	32.25	43.96	45.99
Total Debt/Equity (%)	- -	- -	- -	- -	4	15.65	57.86	121.85	157.96
Total Debt/Capital (%)	- -	- -	- -	- -	-3.13	-6.8	-16.56	-12.92	-7.72
Total Debt/Total Assets (%)	- -	- -	- -	- -	3.59	12.15	32.69	44.56	45.99
Net Debt to Equity	-105.56	-111.08	-111.16	-102.92	-105.35	-105.67	-101.71	-25.57	54.65
Net Debt/Capital (%)	1,910.73	1,004.35	44.57	63.27	45.18	30.44	20.2	2.37	-2.56
EBITDA	-15	-30	-61	-89	-129	-96	-142	-136	-39
EBITDA-CapEx	-15	-31	-61	-90	-131	-96	-142	-136	-39
Operating Income (Loss)	-15	-30	-61	-89	-129	-96	-142	-136	-40

Liquidity (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	10.58	8.41	8.87	29.87	13.62	8.84	8.01	4.08	2.76
Current Ratio	10.96	8.52	8.94	29.94	13.71	9.23	8.82	5.04	3.87
Quick Ratio	10.58	8.41	8.87	29.87	13.62	8.85	8.22	4.39	3.19
CFO/Avg Current Liab	- -	-6.45	-5.83	-6.18	-6.2	-3.88	-5.18	-4.07	-1.17
Common Equity/Total Assets	-132.6	-134.79	-122.77	-57.75	-118.26	-190.81	-230.02	-389.44	-641.75
Long-Term Debt/Equity (%)	- -	- -	- -	- -	3.73	15.65	57.08	120.19	157.96
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-2.92	-6.8	-16.34	-12.75	-7.72
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	3.35	12.15	32.25	43.96	45.99
Total Debt/Equity (%)	- -	- -	- -	- -	4	15.65	57.86	121.85	157.96
Total Debt/Capital (%)	- -	- -	- -	- -	-3.13	-6.8	-16.56	-12.92	-7.72
Total Debt/Total Assets (%)	- -	- -	- -	- -	3.59	12.15	32.69	44.56	45.99
CFO/Total Liabilities	-638.79	-446.95	-428.74	-596.84	-339.79	-163.56	-119.5	-107.89	-44.5
CFO/CapEx	-159.14	-100.56	-171.83	-104.81	-36.66	- -	- -	-254.19	- -
Altman's Z-Score	-2.88	-2.92	15.81	30.3	18.2	5.13	-1.6	-5.46	-7.44

Working Capital (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	- -	- -	- -	- -	- -	382.15	10.62	6.11	6.94
Days Sales Outstanding	- -	- -	- -	- -	- -	0.96	34.35	59.7	52.6
Inventory Turnover	- -	- -	- -	- -	- -	- -	1.16	0.38	0.5
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	314.22	956.81	725.97
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.7	3.19	0.61
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	215.16	114.54	602.86
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	133.41	901.97	175.7
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-279.86	-897.11	-673.37
Inventories	- -	- -	- -	- -	- -	- -	3	16	12
Raw Materials	- -	- -	- -	- -	- -	- -	2	3	2
Work In Process	- -	- -	- -	- -	- -	- -	1	10	10
Finished Goods	- -	- -	- -	- -	- -	- -	- -	3	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	- -	- -	361	638	991	681	428	237	158
- Cash & Cash Equivalents	23	47	104	369	269	207	221	95	32
+ Preferred Equity and Hybrid Capital	53	108	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	10	28	83	84	56
Enterprise Value	30	60	257	269	732	502	290	176	132
Total Capital	22	43	-129	-214	-327	-408	-501	-648	-724
Total Debt/Capital (%)	- -	- -	- -	- -	-3.13	-6.8	-16.56	-12.92	-7.72
Total Debt / EV	- -	- -	- -	- -	0.01	0.06	0.29	0.48	0.42
EV/Sales	58.4	- -	- -	- -	- -	11.08	9.22	3.42	1.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	361	638	991	681	428	237	158
Diluted Enterprise Value	30	60	257	269	732	502	290	226	181
EV per Share	1.49	2.95	14.14	8.07	19.52	13.25	6.92	4.02	2.54
TTM Sales	1	- -	- -	- -	- -	45	31	51	83
TTM EBITDA	-15	-30	-61	-89	-129	-96	-142	-136	-39
TTM Operating Income	-15	-30	-61	-89	-129	-96	-142	-136	-40
TTM Cash Flow to Firm	-14	-25	-51	-74	-100	-82	-127	-118	-28
TTM Free Cash Flow to Firm	-14	-25	-50	-74	-97	-82	-127	-118	-28

Multiples (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	- -	- -	-7.19	-8.67	-10.23	-8.14	-3.24	-1.85	-4.12
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	30	60	257	269	732	502	290	176	132
Low Price	- -	- -	12.04	15.21	13.87	8.8	9.75	3.84	1.08
EV/Sales	58.4	- -	- -	- -	- -	11.08	9.22	3.42	1.59
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.46	-15.82	-7.29	-6.35	-5.25	-2.58	-3.05
Price/Earnings High	- -	- -	-8.04	-27.18	-12.8	-10.29	-10.48	-5.17	-9.06
Price/Earnings Low	- -	- -	-3.38	-5.94	-4.25	-3.36	-2.76	-1.14	-1.16
Price/Book Value	- -	- -	-2.8	-2.98	-2.94	-1.56	-0.73	-0.32	-0.2
Price/Book Value Average	- -	- -	-2.75	-6.29	-2.65	-1.45	-1.33	-0.52	-0.19
Price/Book Value High	- -	- -	-4.04	-10.81	-4.65	-2.34	-2.66	-1.04	-0.56
Price/Book Value Low	- -	- -	-1.7	-2.36	-1.54	-0.76	-0.7	-0.23	-0.07
Price/Tangible Book Value	- -	- -	3.87	1.78	3.88	3.84	2.98	3.45	4.46
Price/Tangible Book Value Average	- -	- -	3.8	3.76	3.49	3.56	5.42	5.54	4.14
Price/Tangible Book Value High	- -	- -	5.59	6.46	6.13	5.76	10.83	11.1	12.28
Price/Tangible Book Value Low	- -	- -	2.35	1.41	2.04	1.88	2.85	2.44	1.58
Price/Sales	- -	- -	- -	- -	- -	15.05	13.61	4.62	1.91
Price/Sales Average	- -	- -	- -	- -	- -	13.93	24.72	7.42	1.77
Price/Sales High	- -	- -	- -	- -	- -	22.55	49.4	14.87	5.27
Price/Sales Low	- -	- -	- -	- -	- -	7.36	12.99	3.27	0.68
Price/Cash Flow	- -	- -	-7.15	-8.59	-9.95	-8.14	-3.24	-1.84	-4.12
Price/Cash Flow Average	- -	- -	-7.02	-18.16	-8.96	-7.53	-5.89	-2.96	-3.82
Price/Cash Flow High	- -	- -	-10.33	-31.19	-15.74	-12.19	-11.77	-5.93	-11.34
Price/Cash Flow Low	- -	- -	-4.34	-6.82	-5.22	-3.98	-3.1	-1.3	-1.46
Price/Free Cash Flow Average	- -	- -	-7.06	-18.33	-9.21	-7.53	-5.89	-2.97	-3.82
Price/Free Cash Flow High	- -	- -	-10.39	-31.49	-16.18	-12.19	-11.77	-5.96	-11.34
Price/Free Cash Flow Low	- -	- -	-4.36	-6.89	-5.37	-3.98	-3.1	-1.31	-1.46
EV/Sales Average	58.4	- -	- -	- -	- -	9.96	20.34	7.21	2.06
EV/Sales High	58.4	- -	- -	- -	- -	18.59	45.01	14.66	5.55
EV/Sales Low	58.4	- -	- -	- -	- -	3.4	8.6	3.05	0.96
EV/EBITDA Average	-1.98	-1.99	-4.12	-11	-4.92	-4.7	-4.51	-2.73	-4.36
EV/EBITDA High	-1.98	-1.99	-6.86	-21.87	-10.17	-8.78	-9.98	-5.55	-11.75
EV/EBITDA Low	-1.98	-1.99	-1.89	-1.54	-2.03	-1.6	-1.91	-1.16	-2.04
EV/EBIT Average	-1.98	-1.98	-4.11	-10.98	-4.91	-4.68	-4.49	-2.72	-4.3
EV/EBIT High	-1.98	-1.98	-6.85	-21.82	-10.14	-8.72	-9.94	-5.52	-11.59
EV/EBIT Low	-1.98	-1.98	-1.89	-1.54	-2.02	-1.59	-1.9	-1.15	-2.01
Last Price	- -	- -	19.84	19.15	26.43	17.99	10.21	5.43	3.05
High Price	- -	- -	28.67	69.57	41.8	26.96	37.07	17.49	8.4
Enterprise Value Average	30	60	251	980	633	451	640	370	170
Enterprise Value High	30	60	418	1,949	1,308	842	1,417	752	458
Enterprise Value Low	30	60	115	137	261	154	271	157	80

Shares Outstanding	27	27	28	37	38	38	43	51	52
Diluted Weighted Avg Shares	20	20	18	33	37	38	42	44	52
Basic Weighted Avg Shares	20	20	18	33	37	38	42	44	52
Revenue per Share	0.03	- -	- -	- -	- -	1.2	0.75	1.18	1.59
EBITDA per Share	-0.75	-1.48	-3.35	-2.67	-3.43	-2.53	-3.39	-3.11	-0.75
Operating Income per Share	-0.75	-1.49	-3.35	-2.68	-3.44	-2.55	-3.4	-3.12	-0.76
Basic EPS, GAAP	-1.06	-1.7	-3.57	-2.56	-3.27	-2.62	-3.54	-3.38	-0.93
Basic EPS from Cont Ops	-0.99	-1.48	-3.3	-2.56	-3.27	-2.62	-3.54	-3.38	-0.93
Diluted EPS, GAAP	-1.06	-1.7	-3.57	-2.56	-3.27	-2.62	-3.54	-3.38	-0.93
Diluted EPS from Cont Ops	-0.99	-1.48	-3.3	-2.56	-3.27	-2.62	-3.54	-3.38	-0.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.68	-1.23	-2.78	-2.23	-2.66	-2.21	-3.15	-2.95	-0.74
Free Cash Flow per Basic Share	-0.68	-1.24	-2.79	-2.25	-2.73	-2.21	-3.15	-2.96	-0.74
Cash & Equivalents per Share	1.12	2.32	5.7	11.08	7.18	5.47	5.27	3.33	1.59
Book Value per Share	-1.55	-3.18	-7.1	-6.44	-8.98	-11.51	-13.93	-16.78	-15.08
Tangible Book Value per Share	-1.55	-3.18	5.13	10.77	6.81	4.68	3.42	1.58	0.68

G1 Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)